Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers

2014-08-27 03:15:12 | BioPortfolio


Using health behavior theories and theories related to the effects of persuasive messages (i.e., inoculation theory), we plan to: 1. Systematically test the effects of brief persuasive message interventions on receipt of the first dose of HPV vaccine; and 2. evaluate the effects of the interventions on followup with subsequent doses of vaccine (using reminder notices with persuasive message content). One set of interventions will involve a comparison of a 1 sided message, which only emphasizes the positive aspects of a recommended behavior, with a 2 sided message, which presents negative aspects of the behavior followed by positive counterarguments. A second set of interventions will involve a test of a social compliance (foot-in-the-door technique, in which half of the parent participants will be asked to respond to a high compliance request (i.e., a request likely to generate high compliance, such as, "Do you want to protect your daughter from cervical cancer?" before subsequently being asked about actually having their daughters vaccinated. The other half of the parents will not receive a high compliance request. Parents of 11-14 year old girls will be randomized to the two sets of interventions, resulting in a 2 X 2 design: message sidedness (1 sided; 2 sided) and social compliance request (yes; no). The specific aims of this proposal are to evaluate the 1) efficacy of 2 sided vs. 1 sided messages on rates of HPV vaccination; 2) the efficacy of a social compliance intervention on rates of HPV vaccination; and 3) potential moderators and mediators of message effect on vaccine acceptance.


The proposed study will employ a randomized, full factorial experimental design to examine the effects of brief message interventions on parents' acceptance of the first dose of HPV vaccine for their daughters aged 11-14 years, as well as follow through with subsequent doses. Specifically, the study will employ a 2 x 2 experimental design, in which participants will be assigned randomly to one of two different message sidedness conditions (1 sided vs. 2 sided) and two social compliance conditions (high compliance request [HCR] vs. noHCR). The interventions will be administered by research assistants who will read, verbatim, scripts provided to them. Computer assisted telephone interview (CATI) will be used to gather demographic and background information as well as parental health beliefs regarding preexisting worries about HPV vaccine leading to sexual disinhibition (moderator variable) prior to administration of the interventions. After the interventions, additional health beliefs will be assessed (mediators).

Hypothesis 1: We expect the 2 sided message to result in higher rates of first dose acceptance of the HPV vaccine compared to the 1 sided message.

Hypothesis 2: We expect the 2 sided message, which will be repeated in appointment reminders sent to the parents, to result in higher rates of 3 dose completion than the 1 sided message, within one year of starting the series. Hypothesis 3: We expect the social compliance intervention to result in higher rates of first dose acceptance of the HPV vaccine compared to the nonintervention group.

Hypothesis 4: We expect the social compliance intervention, which will be repeated in appointment reminders sent to the parents, to result in higher rates of 3 dose completion than the nonintervention group, within one year of starting the series. We also expect that the two interventions will have an additive effect on both first dose acceptance rates and on 3 dose completion.

Hypothesis 5: As predicted by inoculation theory, we expect parents who have preexisting concerns about HPV vaccination of their daughters to be most responsive to the 2 sided compared to the 1 sided message. We expect parents with no preexisting concerns about sexual disinhibition due to HPV vaccination to not differentiate between the two messages. That is, we expect preexisting concerns will moderate the effect of this intervention.

Hypothesis 6: We expect both sets of interventions to alter health beliefs about HPV and the HPV vaccine (e.g., increase perceived severity of HPV infection and perceived benefits of vaccination and decrease perceived barriers to vaccination). We expect that these health beliefs, in turn, will predict acceptance of the vaccine. That is, we expect health beliefs to mediate the effect of the interventions on vaccine uptake.

Study Design

Allocation: Randomized, Control: Uncontrolled, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment


Human Papillomavirus Infection


Compliance, Message sidedness


Teen Health Center, Inc
United States


Not yet recruiting


Indiana University

Results (where available)

View Results


Published on BioPortfolio: 2014-08-27T03:15:12-0400

Clinical Trials [1224 Associated Clinical Trials listed on BioPortfolio]

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

RATIONALE: Vaccines made from human papillomavirus may help the body build an effective immune response to kill HIV cells. PURPOSE: This phase II trial is studying the side effects and ho...

Human Papillomavirus (HPV) Infection in Pregnancy

The purpose of this study is to determine if maternal infection with human papillomavirus (HPV) is associated with pregnancy complications including spontaneous preterm delivery (sPTD), se...

Tailoring of Vaccine-Focused Messages: Disease Salience

This study is the second phase of a trial examining decision making about vaccines. For this phase of this study, the researchers will conduct a 3-arm randomized trial to compare the curre...

HPV Vaccination in Women With Cystic Fibrosis

The main risk factor for the development of cervical lesions is human papillomavirus (HPV) infection. Vaccination against human papillomavirus, which is offered to all girls aged 11 to 14,...

HIV Testing & Womens Attitudes on HIV Vaccine Trials

The purpose of this study is to test the effects of different persuasive informational messages on rates of rapid HIV testing and willingness to participate in a HIV vaccine clinical trial...

PubMed Articles [15617 Associated PubMed Articles listed on BioPortfolio]

Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.

Men who have sex with men (MSM) are at risk for cancers attributable to human papillomavirus (HPV), including oropharyngeal cancer. Human papillomavirus vaccination is recommended for US MSM through a...

Intravaginal practices and genital human papillomavirus infection among female sex workers in Cambodia.

Intravaginal practices (IVPs) include washing, wiping, or inserting something inside the vagina. This study investigates the associations between IVPs and genital human papillomavirus (HPV) infection.

Trajectory modeling for estimating the trend of human papillomavirus infection status among men who have sex with men.

To investigate whether trajectory model can be used to explore the trend of anal human papillomavirus (HPV) infection status among HIV-negative men who have sex with men (MSM).

Variants in Immune-related Genes and Genital HPV 16 Persistence in Men.

While most human papillomavirus (HPV) infection clears on its own, persistent HPV infection can cause genital warts and anal, penile and oropharyngeal cancers in men. We conducted genetic analysis in ...

Human papillomavirus infection and cervical cancer precursor lesions in women living by Amazon rivers: investigation of relations with markers of oxidative stress.

Objective To investigate the relation between oxidative stress markers, human papillomavirus infection and cervical cancer precursor lesions. Methods The study comprised women aged 14 to 60 years livi...

Medical and Biotech [MESH] Definitions

A type of human papillomavirus especially associated with malignant tumors of the genital and RESPIRATORY MUCOSA.

Distensibility measure of a chamber such as the lungs (LUNG COMPLIANCE) or bladder. Compliance is expressed as a change in volume per unit change in pressure.

Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.

ONCOGENE PROTEINS from papillomavirus that deregulate the CELL CYCLE of infected cells and lead to NEOPLASTIC CELL TRANSFORMATION. Papillomavirus E7 proteins have been shown to interact with various regulators of the cell cycle including RETINOBLASTOMA PROTEIN and certain cyclin-dependent kinase inhibitors.

A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from HUMAN PAPILLOMAVIRUSES of these subtypes.

More From BioPortfolio on "Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers"

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Searches Linking to this Trial